Compounds > farnesol

farnesol and HIV Coinfection

farnesol has been researched along with HIV Coinfection in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gatanaga, H; Kawamura, T; Koyanagi, Y; Maeda, K; Matsuzawa, T; Mitsuya, H; Moriishi, K; Nakata, H; Ogawa, Y; Shimada, S1
Dezzutti, CS; Gong, T; Hu, M; Moncla, B; Parniak, MA; Rohan, LC; Sarafianos, SG; Shi, Y; Zhang, W1
Galkina, SA; Joshi, P; Kosikova, G; Moreno, ME; Murphey-Corb, M; Parniak, MA; Reeve, AB; Rivera, JM; Sarafianos, SG; Sloan, B; Stoddart, CA1
András, IE; Eum, SY; Toborek, M1
Beard, MR; Bye, CR; Cunningham, AL; Donaghy, H; Harman, AN; Helbig, KJ; Maddocks, S; Nasr, N; Rambukwelle, D; Turville, SG; Wilkinson, J; Woolger, N; Wright, TK1

Other Studies

5 other study(ies) available for farnesol and HIV Coinfection

ArticleYear
EFdA, a reverse transcriptase inhibitor, potently blocks HIV-1 ex vivo infection of Langerhans cells within epithelium.
    The Journal of investigative dermatology, 2014, Volume: 134, Issue:4

    Topics: Administration, Topical; Animals; Anti-HIV Agents; Anti-Infective Agents; CD4-Positive T-Lymphocytes; Coculture Techniques; Diazonium Compounds; Dose-Response Relationship, Drug; Epithelium; Farnesol; HIV Infections; HIV-1; Humans; Langerhans Cells; Mice; Reverse Transcriptase Inhibitors; Skin

2014
Vaginal Microbicide Film Combinations of Two Reverse Transcriptase Inhibitors, EFdA and CSIC, for the Prevention of HIV-1 Sexual Transmission.
    Pharmaceutical research, 2015, Volume: 32, Issue:9

    Topics: Administration, Intravaginal; Anti-HIV Agents; Anti-Infective Agents; Cell Line; Chemistry, Pharmaceutical; Diazonium Compounds; Drug Therapy, Combination; Farnesol; Female; HIV Infections; HIV-1; Humans; Indoles; Lactobacillus; Reverse Transcriptase Inhibitors; Vagina

2015
Oral administration of the nucleoside EFdA (4'-ethynyl-2-fluoro-2'-deoxyadenosine) provides rapid suppression of HIV viremia in humanized mice and favorable pharmacokinetic properties in mice and the rhesus macaque.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:7

    Topics: Animals; Anti-HIV Agents; Blood-Brain Barrier; Diazonium Compounds; Farnesol; Flow Cytometry; Half-Life; HIV Infections; HIV-1; Humans; In Vitro Techniques; Macaca mulatta; Mice; Mice, SCID; Monocytes; Reverse Transcriptase Inhibitors; RNA, Viral; Simian Immunodeficiency Virus; Viremia

2015
Lipid rafts and functional caveolae regulate HIV-induced amyloid beta accumulation in brain endothelial cells.
    Biochemical and biophysical research communications, 2012, May-04, Volume: 421, Issue:2

    Topics: Amyloid beta-Peptides; Brain; Caveolae; Cells, Cultured; Endothelial Cells; Enzyme Inhibitors; Farnesol; HIV Infections; HIV-1; Humans; Membrane Microdomains; ras Proteins; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Salicylates

2012
HIV-1 infection of human macrophages directly induces viperin which inhibits viral production.
    Blood, 2012, Jul-26, Volume: 120, Issue:4

    Topics: Amino Acid Sequence; Antiviral Agents; Biomarkers; Blotting, Western; Dendritic Cells; Farnesol; Flow Cytometry; Gene Expression Profiling; HIV Infections; HIV-1; Humans; Immunoenzyme Techniques; Immunoprecipitation; Interferons; Macrophages; Molecular Sequence Data; Monocytes; Mutagenesis, Site-Directed; Mutation; Oligonucleotide Array Sequence Analysis; Oxidoreductases Acting on CH-CH Group Donors; Protein Prenylation; Proteins; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Sequence Homology, Amino Acid; Virus Replication

2012